Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Zhang, Wei, Wang, Tongguang, Pei, Zhong, Miller, David S., Wu, Xuefei, Block, Michelle L., Wilson, Belinda, Zhang, Wanqin +3 more·2005·The FASEB Journal

Cited by (1,000)

Items 201–300 of 1,000

  1. Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides
    Reglodi, Dora, Renaud, Justine, Tamas, Andrea, Tizabi, Yousef, Socías, Sergio B., Del-Bel, Elaine, Raisman-Vozari, Rita · 2017 · Progress in Neurobiology
  2. Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease
    Fabio Blandini · 2013 · Journal of Neuroimmune Pharmacology
  3. Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases
    Stewart Siyan Cao, Katherine L. Luo, Lynn Shi · 2015 · Journal of Cellular Physiology
  4. Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
    Fellner, Lisa, Jellinger, Kurt A., Wenning, Gregor K., Stefanova, Nadia · 2011 · Acta Neuropathologica
  5. Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
    Annadurai Anandhan, Maria S. Jacome, Shulei Lei, Pablo Hernández-Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Robert Powers, Rodrigo Franco · 2017 · Brain Research Bulletin
  6. Oxidative Stress and Microglial Cells in Parkinson's Disease
    Lynda J. Peterson, Patrick M. Flood · 2012 · Mediators of Inflammation
  7. Microglial PHOX and Mac‐1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha‐synuclein
    Wei Zhang, Shannon Dallas, Dan Zhang, Jian‐Ping Guo, Hao Pang, Belinda C. Wilson, David S. Miller, Biao Chen, Wanqin Zhang, Patrick L. McGeer et al. · 2007 · Glia
  8. The cell biology of Parkinson’s disease
    Nikhil Panicker, Preston Ge, Valina Lynn Dawson, Ted M. Dawson · 2021 · The Journal of Cell Biology
  9. Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease
    Seung‐Jae Lee · 2007 · Journal of Molecular Neuroscience
  10. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice
    Daniel Alvarez‐Fischer, Carmen Henze, Corinna Strenzke, Jan Westrich, Boris Ferger, Günter U. Höglinger, Wolfgang Hermann Oertel, Andreas Hartmann · 2007 · Experimental Neurology
  11. Microglia activation states and cannabinoid system: Therapeutic implications
    Míriam Mecha, Francisco Javier Carrillo-Salinas, Ana Feliú, Leyre Mestre, Carmen Guaza · 2016 · Pharmacology & Therapeutics
  12. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant
    Hoenen, Claire, Gustin, Audrey, Birck, Cindy, Kirchmeyer, Mélanie, Beaume, Nicolas, Felten, Paul, Grandbarbe, Luc, Heuschling, Paul, Heurtaux, Tony · 2016 · PLOS ONE
  13. Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation
    Zhang, Qiu-Shuang, Heng, Yang, Yuan, Yu-He, Chen, Nai-Hong · 2017 · Toxicology Letters
  14. Exosomes of BV-2 cells induced by alpha-synuclein: Important mediator of neurodegeneration in PD
    Chongwang Chang, Hongjuan Lang, Ning Geng, Jing Wang, Nan Li, Xuelian Wang · 2013 · Neuroscience Letters
  15. The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
    Couch, Yvonne, Alvarez-Erviti, Lydia, Sibson, Nicola R, Wood, Matthew JA, Anthony, Daniel C · 2011 · Journal of Neuroinflammation
  16. Role of Endogenous Lipopolysaccharides in Neurological Disorders
    Manjunath Kalyan, Tousif Ahmed Hediyal, Sharma Sonali, Chandrasekaran Vichitra, Tuladhar Sunanda, Sankar Simla Praveenraj, Bipul Ray, Vasavi Rakesh Gorantla, Wiramon Rungratanawanich, Arehally Marappa Mahalakshmi et al. · 2022 · Cells
  17. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
    Drouin-Ouellet, J., St-Amour, I., Saint-Pierre, M., Lamontagne-Proulx, J., Kriz, J., Barker, R. A., Cicchetti, F. · 2015 · International Journal of Neuropsychopharmacology
  18. Metal Dyshomeostasis and Inflammation in Alzheimer’s and Parkinson’s Diseases: Possible Impact of Environmental Exposures
    Oddvar Myhre, Hans Utkilen, Nur Duale, Gunnar Brunborg, Tim Hofer · 2013 · Oxidative Medicine and Cellular Longevity
  19. α-Synuclein, a chemoattractant, directs microglial migration via H 2 O 2 -dependent Lyn phosphorylation
    Shijun Wang, Chun‐Hsien Chu, Tessandra Stewart, Carmen Ginghină, Yifei Wang, Hui Nie, Mingri Guo, Belinda C. Wilson, Jau‐Shyong Hong, Jing Zhang · 2015 · Proceedings of the National Academy of Sciences
  20. Innate and adaptive immune responses in the CNS
    Ari Waisman, Roland Liblau, Burkhard Becher · 2015 · The Lancet Neurology
  21. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat
    S. R. Walsh, David P. Finn, Eilís Dowd · 2010 · Neuroscience
  22. Microglial phagocytosis is enhanced by monomeric α‐synuclein, not aggregated α‐synuclein: Implications for Parkinson's disease
    Ji‐Young Park, Seung R. Paik, Ilo Jou, Sang Myun Park · 2008 · Glia
  23. Oxidative and nitrative alpha‐synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies
    Schildknecht, Stefan, Gerding, Hanne R., Karreman, Christiaan, Drescher, Malte, Lashuel, Hilal A., Outeiro, Tiago F., Di Monte, Donato A., Leist, Marcel · 2013 · Journal of Neurochemistry
  24. Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
    Kouli, Antonina, Horne, C.B., Williams-Gray, C.H. · 2019 · Brain Behavior and Immunity
  25. PPAR: a therapeutic target in Parkinson’s disease
    Rajnish Kumar Chaturvedi, M. Flint Beal · 2008 · Journal of Neurochemistry
  26. Inflammatory Activation of Microglia and Astrocytes in Manganese Neurotoxicity
    Ronald B. Tjalkens, Katriana A. Popichak, Kelly A. Kirkley · 2017 · Advances in neurobiology
  27. Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
    Su, Xiaomin, Federoff, Howard J., Maguire-Zeiss, Kathleen A. · 2009 · Neurotoxicity Research
  28. Astrocytes, Microglia, and Parkinson’s Disease
    Eun-hye Joe, Dong‐Joo Choi, Jiawei An, Jin-Hwa Eun, Ilo Jou, Sang-Myun Park · 2018 · Experimental Neurobiology
  29. Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice
    Jérôme Ausseil, Nathalie Desmaris, Stéphanie Bigou, Ruben Attali, Sébastien Corbineau, Sandrine Vitry, Mathieu Parent, David Cheillan, Maria Fuller, Irène Maire et al. · 2008 · PLoS ONE
  30. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson’s disease: possible implications of glial cells
    Toshiharu Nagatsu, Makoto Sawada · 2006 · Springer eBooks
  31. Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
    Cynthia Lecours, Maude Bordeleau, Léo Cantin, Martin Parent, Thérèse Di Paolo, Marie‐Ève Tremblay · 2018 · Frontiers in Cellular Neuroscience
  32. The immune system in Parkinson's disease: what we know so far
    Cintia Roodveldt, Liliana Inácio Bernardino, Özgür Öztop Çakmak, Milorad Dragić, Kari Espolin Fladmark, Sibel Ertan, Büşra Aktaş, Carlos Pita, Lucia Ciglar, Gaëtan Garraux et al. · 2024 · Brain
  33. Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells
    Andis Klegeris, Benoit I. Giasson, Hong Zhang, John A. Maguire, Steven Pelech, Patrick L. McGeer · 2006 · The FASEB Journal
  34. Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases
    Vanessa Silva Gontijo, Flávia Pereira Dias Viegas, Cindy Juliet Cristancho Ortiz, Matheus de Freitas Silva, Caio Miranda Damásio, Mayara Chagas Rosa, Thâmara Gaspar Campos, Dyecika Souza Couto, Kris Simone Tranches Dias, Cláudio Viegas · 2019 · Current Neuropharmacology
  35. Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
    Caiyun Liu, Xu Wang, Chang Liu, Hongliang Zhang · 2019 · Frontiers in Cellular Neuroscience
  36. α-Synuclein Expression Modulates Microglial Activation Phenotype
    Susan A. Austin, Angela Marie Floden, Eric J. Murphy, Colin Kelly Combs · 2006 · Journal of Neuroscience
  37. Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
    Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
  38. Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
    Juan I. Sbodio, Solomon H. Snyder, Bindu Diana Paul · 2018 · Antioxidants and Redox Signaling
  39. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson’s Disease
    Kai-Jung Lin, Kai-Lieh Lin, Shang‐Der Chen, Chia‐Wei Liou, Yao‐Chung Chuang, Hung‐Yu Lin, Tsu‐Kung Lin · 2019 · International Journal of Molecular Sciences
  40. Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
    Desai Bradaric, Brinda, Patel, Aditiben, Schneider, Julie A., Carvey, Paul M., Hendey, Bill · 2012 · Journal of Neural Transmission
  41. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta
    Jyothi, H.J., Vidyadhara, D.J., Mahadevan, Anita, Philip, Mariamma, Parmar, Suresh Kumar, Manohari, S. Gowri, Shankar, S.K., Raju, Trichur R., Alladi, Phalguni Anand · 2015 · Neurobiology of Aging
  42. Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum
    Tasuku Konno, Eduardo P. Melo, Joseph E. Chambers, Edward Avezov · 2021 · Cells
  43. Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
    Saviana Di Giovanni, Simona Eleuteri, Katerina E. Paleologou, Guowei Yin, Markus Zweckstetter, Pierre‐Alain Carrupt, Hilal Ahmed Lashuel · 2010 · Journal of Biological Chemistry
  44. Innate Immunity and Protective Neuroinflammation: New Emphasis on the Role of Neuroimmune Regulatory Proteins
    Mark Griffiths, James Neal, Philippe Gasque · 2007 · International review of neurobiology
  45. Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
    Veronica Lindström, Therese Fagerqvist, Eva K. L. Nordström, Fredrik Eriksson, Anna Lord, Stina Maria Tucker, Jessica Andersson, Malin Johannesson, Heinrich Schell, Philipp J. Kahle et al. · 2014 · Neurobiology of Disease
  46. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
    Baizabal-Carvallo, José Fidel, Alonso-Juarez, Marlene · 2020 · Neuroscience
  47. Physical activity and exercise attenuate neuroinflammation in neurological diseases
    Lindsay Joy Spielman, Jonathan P. Little, Andis Klegeris · 2016 · Brain Research Bulletin
  48. Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
    Dawn Béraud, Kathleen A. Maguire‐Zeiss · 2011 · Parkinsonism & Related Disorders
  49. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease
    Schapansky, J., Nardozzi, J.D., LaVoie, M.J. · 2015 · Neuroscience
  50. Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein
    Jun Liu, Jianpeng Zhang, Min Yan Shi, Thomas J. Quinn, Joshua M. Bradner, Richard Beyer, Shengdi Chen, Jing Zhang · 2009 · Journal of Neuroscience
  51. Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
    David K. Stone, Ashley D. Reynolds, Rodney Lee Mosley, Howard Eliot Gendelman · 2009 · Antioxidants and Redox Signaling
  52. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors
    Michael J. Surace, Michelle L. Block · 2012 · Cellular and Molecular Life Sciences
  53. Genetic and Environmental Factors in P arkinson's Disease Converge on Immune Function and Inflammation
    Elizabeth M. Kline, Madelyn C. Houser, Mary K. Herrick, Philip Seibler, Christine Klein, Andrew B. West, Malú G. Tansey · 2020 · Movement Disorders
  54. Helical α-Synuclein Forms Highly Conductive Ion Channels
    L.N. Zakharov, John D. Hulleman, Elena A. Dutseva, Yuri N. Antonenko, Jean‐Christophe Rochet, William A Cramer · 2007 · Biochemistry
  55. Suppression of Microglial Inflammatory Activity by Myelin Phagocytosis: Role of p47-PHOX-Mediated Generation of Reactive Oxygen Species
    Yang Liu, Wenlin Hao, Maryse Letièmbre, Silke Walter, Miroslav Kulanga, Harald Neumann, Klaus C Fassbender · 2006 · Journal of Neuroscience
  56. α-Synuclein and Neuronal Cell Death
    Toru Yasuda, Yasuto Nakata, Hideki Mochizuki · 2012 · Molecular Neurobiology
  57. Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Isabella Russo, Giulia Berti, Nicoletta Plotegher, Greta Bernardo, Roberta Filograna, Luigi Bubacco, Elisa Greggio · 2015 · Journal of Neuroinflammation
  58. Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities
    Ashley D. Reynolds, Irena Kadiu, Sanjay Kumar Garg, Jason G. Glanzer, Tara M. Nordgren, Pawel S. Ciborowski, Ruma V. Banerjee, Howard Eliot Gendelman · 2008 · Journal of Neuroimmune Pharmacology
  59. Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
    Araks Martirosyan, Rizwan Ahmad Ansari, Francisco Pestana, Katja Hebestreit, Hayk A. Gasparyan, Razmik Aleksanyan, Silvia Hnatova, Suresh Kumar Poovathingal, Catherine Marneffe, Dietmar Rudolf Thal et al. · 2024 · Molecular Neurodegeneration
  60. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
    Minee L. Choi, Sonia Gandhi · 2018 · FEBS Journal
  61. α‐Synuclein evokes NLRP3 inflammasome‐mediated IL ‐1β secretion from primary human microglia
    Adrianne F. Pike, Tatiana Varanita, Maaike A. C. Herrebout, Bonnie C. Plug, Jeroen Kole, René J.P. Musters, Charlotte Elisabeth Teunissen, Jeroen J.M. Hoozemans, Luigi Bubacco, Robert Veerhuis · 2021 · Glia
  62. Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]‐PK11195 PET
    Anna L. Bartels, Klaus Leonhard Leenders · 2007 · Movement Disorders
  63. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
    Tapias, Victor, Hu, Xiaoping, Luk, Kelvin C., Sanders, Laurie H., Lee, Virginia M., Greenamyre, J. Timothy · 2017 · Cellular and Molecular Life Sciences
  64. ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
    Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, Ronald Melki · 2018 · Cell and Tissue Research
  65. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson’s disease
    Mark P. Thomas, Katie Chartrand, Ashley D. Reynolds, Victor Vitvitsky, Ruma V. Banerjee, Howard Eliot Gendelman · 2006 · Journal of Neurochemistry
  66. On the mechanism of internalization of α‐synuclein into microglia: roles of ganglioside GM1 and lipid raft
    Park, Ji‐Young, Kim, Kwang Soo, Lee, Saet‐Byul, Ryu, Jae‐Sung, Chung, Kwang Chul, Choo, Young‐Kug, Jou, Ilo, Kim, Jongsun, Park, Sang Myun · 2009 · Journal of Neurochemistry
  67. Neuroinflammation and Peripheral Immune Infiltration in Parkinson's Disease: An Autoimmune Hypothesis
    Angela J. Monahan, Michael Warren, Paul M. Carvey · 2008 · Cell Transplantation
  68. Phagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease
    Milan Fiala, David H. Cribbs, Mark J. Rosenthal, George W. Bernard · 2007 · Journal of Alzheimer s Disease
  69. P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
    Jiang, Tianfang, Hoekstra, Jake, Heng, Xin, Kang, Wenyan, Ding, Jianqing, Liu, Jun, Chen, Shengdi, Zhang, Jing · 2015 · Neurobiology of Aging
  70. Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
    Neal, Matthew L., Fleming, Sheila M., Budge, Kevin M., Boyle, Alexa M., Kim, Chunki, Alam, Gelareh, Beier, Eric E., Wu, Long‐Jun, Richardson, Jason R. · 2020 · The FASEB Journal
  71. Cellular and molecular mechanisms of antioxidants in Parkinson's disease
    Jhon Jairo Sutachan, Zulma Casas, Sonia Luz Albarracín, Bernd R. Stab, Ismael J. Samudio, Janneth González, Ludis Morales, George Emilio Barreto · 2012 · Nutritional Neuroscience
  72. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
    Adrianne F. Pike, Francesca Longhena, Gaia Faustini, Jean-Marc van Eik, Iris Gombert, Maaike A. C. Herrebout, Mona M.H.E Fayed, Michele Sandre, Tatiana Varanita, Charlotte Elisabeth Teunissen et al. · 2022 · Journal of Neuroinflammation
  73. Role of Microglia in Autism: Recent Advances
    Tomoyuki Takano · 2015 · Developmental Neuroscience
  74. Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
    Antonio Heras‐Garvin, Daniel Weckbecker, Sergey Ryazanov, Andrei Leonov, Christian Griesinger, Armin Giese, Gregor Karl Wenning, Nadia Stefanova · 2018 · Movement Disorders
  75. Inflammatory Effects of Highly Pathogenic H5N1 Influenza Virus Infection in the CNS of Mice
    Haeman Jang, David A. Boltz, Jennifer L. McClaren, Amar K. Pani, Michelle Smeyne, Ané Korff, Robert G. Webster, Richard Jay Smeyne · 2012 · Journal of Neuroscience
  76. Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain
    Parakalan Rangarajan, Boran Jiang, Nimmi Baby, Janani Manivannan, Manikandan Jayapal, Jia Lu, Samuel Sam Wah Tay, Eng‐Ang Ling, Shaikali Thameem Dheen · 2012 · BMC Neuroscience
  77. GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
    Lisa M. Kosloski, Elizabeth A. Kosmacek, Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2013 · Journal of Neuroimmunology
  78. Chapter 6 Molecular and Cellular Biology of Synucleins
    Andrei P. Surguchov · 2008 · International review of cytology
  79. Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
    Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos‐Diaz, Janice Robertson, Todd Eliot Golde, Benoit I. Giasson · 2014 · Acta Neuropathologica
  80. Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout mice
    Sachiko Tanaka, Atsuko Ishii, Hirokazu Ohtaki, Seiji Shioda, Takemi Yoshida, Satoshi Numazawa · 2013 · Journal of Neuroinflammation
  81. Modeling α-Synuclein Propagation with Preformed Fibril Injections
    Hyun Kyung Chung, Hoang-Anh Ho, Dayana Pérez-Acuña, Seung‐Jae Lee · 2019 · Journal of Movement Disorders
  82. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
    A-L Mahul-Mellier, Filip Vercruysse, Bohumil Maco, Nadine Ait‐Bouziad, Mathias De Roo, Dominique Müller, Hilal Ahmed Lashuel · 2015 · Cell Death and Differentiation
  83. Mesenchymal stem cells enhance α-synuclein clearance via M2 microglia polarization in experimental and human parkinsonian disorder
    Hyun-Jung Park, Se Hee Oh, Hana Kim, Yu Ju Jung, Phil Hyu Lee · 2016 · Acta Neuropathologica
  84. High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways
    Yi Quan, Changtao Jiang, Bing Xue, Shigong Zhu, Xian Wang · 2011 · Acta Pharmacologica Sinica
  85. The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia
    Shuwen Cao, David G. Standaert, Ashley S. Harms · 2012 · Journal of Neuroinflammation
  86. Innate Inflammation in Parkinson's Disease
    Victor Hugh Perry · 2012 · Cold Spring Harbor Perspectives in Medicine
  87. Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
    Jinghua Jin, Feng‐Shiun Shie, Jun Liu, Yan Wang, Jeanne Davis, Aimee M. Schantz, Kathleen S. Montine, Thomas Jude Montine, Jing Zhang · 2007 · Journal of Neuroinflammation
  88. Microglia and inflammation: conspiracy, controversy or control?
    Adelaide Maria Afonso Fernandes, Leonor Miller‐Fleming, Teresa Faria Pais · 2014 · Cellular and Molecular Life Sciences
  89. Plasticity of microglia
    Marcus Augusto‐Oliveira, Gabriela de Paula Arrifano, Charlotte Isabelle Delage, Marie‐Ève Tremblay, Maria Elena Crespo Lopez, Alexei Verkhratsky · 2021 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  90. Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
    Giuseppe Arena, Karan Sharma, Gideon Agyeah, Rejko Krüger, Anne Grünewald, Julia Catherine Fitzgerald · 2022 · Current Neurology and Neuroscience Reports
  91. Cellular and molecular pathophysiology in the progression of Parkinson’s disease
    Vandana Zaman, Donald C. Shields, Ramsha Shams, Kelsey P. Drasites, Denise D Matzelle, Azizul Haque, Naren Lal Banik · 2021 · Metabolic Brain Disease
  92. α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
    Vanesa Sánchez-Guajardo, Ambra Annibali, Poul Henning Jensen, Marina Romero‐Ramos · 2013 · Journal of Neuropathology & Experimental Neurology
  93. Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK
    Wang, Xi-Jin, Zhang, Shi, Yan, Zhi-Qiang, Zhao, Yan-Xin, Zhou, Hai-Yan, Wang, Ying, Lu, Guo-Qiang, Zhang, Jing-Dong · 2011 · Free Radical Biology and Medicine
  94. Fractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
    Kevin R. Nash, Peter Moran, Dylan J. Finneran, Charles Hudson, Jesse Robinson, David Morgan, Paula C. Bickford · 2014 · Molecular Therapy
  95. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction
    Zhenwei Yu, Min Yan Shi, Tessandra Stewart, Pierre‐Olivier Fernagut, Yang Xin Rui Huang, Chen Tian, Benjamin Dehay, Anzari Atik, Dishun Yang, Francesca De Giorgi et al. · 2020 · Brain
  96. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
  97. Reactive Oxygen Species and Inhibitors of Inflammatory Enzymes, NADPH Oxidase, and iNOS in Experimental Models of Parkinson’s Disease
    Sushruta Koppula, Hemant Kumar, In Su Kim, Dong‐Kug Choi · 2012 · Mediators of Inflammation
  98. Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
    Rojanathammanee, Lalida, Murphy, Eric J, Combs, Colin K · 2011 · Journal of Neuroinflammation
  99. Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways
    Sun Hyo Jo, Mi Eun Kim, Jun Hwi Cho, Yujeong Lee, Jaewon Lee, Yong‐Duk Park, Jun Sik Lee · 2019 · Archives of Pharmacal Research
  100. Can Parkinson's disease pathology be propagated from one neuron to another?
    Christopher J.R. Dunning, Juan F. Reyes, Jennifer A. Steiner, Patrik Brundin · 2011 · Progress in Neurobiology